The Boston Globe reports that health care giant Johnson & Johnson must pay a Massachusetts teenager and her parents $109 million over claims that the pain reliever Motrin triggered a life-threatening bout of Stevens-Johnson Syndrome, a court ruled.
Stevens Johnson syndrome, which can cause the top layer of skin to shed and die, is usually an allergic reaction in response to medication, infection or illness.
The story says Samantha Reckis was 7 when her parents began giving her Motrin brand ibuprofen to ...
continue reading...
A story in the Macomb Daily out of Michigan concerns a local boy who is participating in a U.S. Food and Drug Administration clinical trial on the use of umbilical cord blood-stem cells for lessening the effects of cerebral palsy.
In a bipartisan effort, U.S. Senators have reintroduced legislation banning a pharmaceutical industry practice that keeps lower-cost medications away from patients who need them. The practice, commonly called “pay for delay,” occurs when one drug company pays another to delay introducing a less-expensive generic version of a medication.
In a Los Angeles Superior Court trial, an occupational medicine specialist testified that a man’s artificial hip had to be removed because of “toxic exposure” from metal debris that the implant was shedding, according to a Reuters story.
The U.S. Food and Drug Administration will hold off on approving Novo Nordisk’s diabetes medication Tresiba, a long-acting insulin, until the company conducts extra tests to address heart risks.
A report on the blog FiercePharma says the approval of blood thinner Eliquis in Europe has the manufacturers of competing medications “on their toes.”
